Julen
Oyarzabal Santamarina
Investigador hasta 2018
Instituto Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto Cajal (2)
2017
-
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice
Neuropsychopharmacology, Vol. 42, Núm. 2, pp. 524-539